There is no experimental evidence of embryopathic or teratogenic effects, but as with all drugs, Ceftazidime (Fortum) should be administered with caution during the early months of pregnancy and early infancy.
Ceftazidime is excreted in human milk in small quantities and should be used with caution in breast feeding.
Other Services
Country
Account